FdaApplication

ANDA 216890

Back to search

Identifiers

Properties

PropertyValue
applicant_nameBRECKENRIDGE PHARMACEUTICAL INC
application_typeANDA
approval_date2022-11-08

Products (2)

ProductActive ingredientStrengthDosage form
TRIAZOLAMTRIAZOLAM0.25MGTABLET;ORAL
TRIAZOLAMTRIAZOLAM0.125MGTABLET;ORAL

2 products